Skip to main content

CRASH-3 TRIAL (Tranexamic Acid in Head Injury)













 

Comments

Popular posts from this blog

EMERGENCY MEDICINE: WHO IS RESISTING YOU TO BECOME A PIONEER OF THE DEVELOPMENT? I am writing this article as I feel a lot medical graduates in India are ignoring a beautiful branch for post-graduation In the 1960's and 70's Radiodiagnosis was the growing branch in developed countries, few countries had the sophistication of using CT-Scan Machines and MRI's.. But, doctors of the developing countries, failed to foresee the change, and top rankers were not choosing the branch.. but gradually the grandeur of the subject spread! Now its the 2020s and Emergency Medicine is a booming subject, with a huge scope in abroad and India. Hi, I am Dr. Subhadeep, I am an Emergency Medicine PG resident in India. I am an old contender to join the course of MD Emergency Medicine in 2022, since I passed my MBBS way back in 2013.. After my internship (rotatory-house physician duty), I did one year house-staffship (served as house physician) in Physical Medicine and Rehabilitation. After wards,

SALSA Trial

The "Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia:  The SALSA Randomized Clinical Trial" published in JAMA, is a significant clinical trial that specifically investigated the use of slow continuous infusion therapies of hypertonic saline with fast bolus replacement, for patients with symptomatic hyponatremia.  Background:   Symptomatic hyponatremia is a condition in which patients have low sodium levels in the blood, leading to neurological symptoms and potentially life-threatening complications. Rapid correction of sodium levels is necessary in such cases to alleviate symptoms and prevent harm. Objective:   The SALSA trial aimed to assess the efficacy and safety of two different strategies for correcting symptomatic hyponatremia using hypertonic saline solutions.  Methods: The study was a randomized clinical trial involving patients with symptomatic hyponatremia. Participants were divided into two groups:  Bolus Therapy G